Can Preventive Care Be Too Fragmented to Work?

Discussion about treatment results

Written by Ryan Harris,

You can do everything you’re supposed to do and still not know whether anyone has looked at the whole picture.

They had the physical. They got the bloodwork. Maybe they saw a cardiologist, scheduled the mammogram, had a skin check, and finally followed through on that referral from last year. Ask what all those appointments added up to, though, and the answer may be harder to find.

The trouble usually isn’t a complete lack of care. It’s that the care happened in pieces. Different offices saw different parts of the story, at different times, in different systems.

That can leave a patient with plenty of medical activity but no obvious plan.

When separate appointments stop adding up

Specialists are part of good care. The problem is that each specialist is working from a narrower part of the record, while primary care may not have every result in front of them.

Sometimes the patient ends up filling the gaps, repeating the history at each visit and trying to remember which office has which result.

Picture a fairly common sequence. A primary care doctor notices something in routine bloodwork and recommends additional testing. The test is performed at an outside facility. A specialist reviews one part of it three weeks later. Another result lands in a patient portal without much context. By the next primary care visit, several people may have touched the case, but the information can still be sitting in separate records.

For someone who has trouble fitting several appointments into a workweek, a comprehensive executive physical can put imaging, lab work, physical testing, and physician review into a single visit. The useful part isn’t simply doing more tests in less time. It’s having the results considered together rather than arriving as disconnected pieces over several months.

AHRQ has documented how communication problems in outpatient care can create safety issues. Its work on patient safety in ambulatory care covers practical risks around referrals, medication information, test results, and follow-up when several people are involved in the same patient’s care.

AIHCP’s overview of the health care delivery system also shows how many parts sit behind a single visit. Records, referrals, facilities, payment, and follow-up all have to connect well enough for the next clinician to know what has already happened.

The problems are often small enough that they don’t look important at first. A medication list is outdated in one chart. A specialist asks for a scan the patient assumed had already been sent. Two doctors order similar blood tests because neither can see the other’s recent results. A referral is placed, but no appointment is ever made.

One missed handoff probably won’t unravel a person’s preventive care. Several of them can.

More testing can create its own kind of confusion

One response to fragmented care is to order more tests, hoping a larger set of results will provide a clearer answer.

More testing can help in the right situation, but it can also leave the patient with a larger pile of results that still need interpretation.

Screening also depends heavily on the person being screened. The U.S. Preventive Services Task Force changes recommendations based on age, sex, smoking history, pregnancy status, and other risk factors, so the same test may be appropriate for one patient and unnecessary for another.

Consider two 48-year-olds. One has a family history of early heart disease, rising blood pressure, and metabolic markers that have been moving in the wrong direction. The other has none of those issues but is overdue for routine cancer screening. Giving both the same giant checklist of tests may look thorough, but it doesn’t necessarily make either person’s care more thoughtful.

The reverse happens too. Someone gets a basic lab panel, sees mostly normal numbers, and takes that as evidence that everything important has been covered. An age-appropriate screening may still be overdue, or a follow-up recommended last year may never have been scheduled.

A test has limited value if nobody reviews what it changes about the patient’s care.

One result rarely settles the question by itself. A mildly abnormal number that has been stable for years may be less concerning than a result still inside the reference range but moving quickly. Medications, symptoms, family history, weight changes, earlier imaging, and new diagnoses all affect how a clinician interprets the number.

That is easier to judge when the clinician can see the previous results and the surrounding history instead of opening one portal at a time.

Otherwise, the patient may leave with a long list of results but no clear sense of what needs attention.

The six-month follow-up is often more important than the February physical

Say a patient has a routine physical in February and their cholesterol is higher than it was last year. The doctor suggests a few changes and asks for another lab test in six months.

Life moves on.

In April, the patient goes to urgent care for something unrelated. In June, a cardiologist gets involved because of family history. August comes around, but the repeat test isn’t on anyone’s calendar. The patient assumes the cardiologist is watching the issue. The cardiologist thought primary care was handling it. Primary care is waiting for the patient to schedule the lab.

There was no dramatic failure. Nobody ignored an emergency. A fairly ordinary follow-up simply fell into the space between offices.

By itself, that missed repeat test may not seem serious, but it means the original plan was never completed.

AHRQ defines care coordination around organizing care and sharing information among the people involved. In practice, that can be as basic as checking whether a referral happened, reading the specialist’s note, confirming repeat labs were completed, and deciding which clinician is responsible for follow-up.

AIHCP’s discussion of case management and utilization review deals with similar questions from a professional perspective. Completing the appointment is only part of the job. Someone still needs to check what came out of it, whether another step is due, and who is meant to handle it.

Patients feel the difference immediately.

“Your labs look mostly fine” isn’t much of a plan.

“Your blood pressure looks good, your cholesterol needs another check in September, and you’re still due for the screening we discussed last year” is something a person can act on.

The second conversation doesn’t require more technology or a more expensive test. It requires someone to keep track of the unfinished business.

Patients shouldn’t have to coordinate everything themselves

Being an engaged patient helps. In practice, that may mean carrying an updated medication list, knowing the important parts of your family history, keeping major reports handy, and asking what needs to happen after the visit.

But patients shouldn’t have to chase every record, referral, and result themselves just to keep the process moving.

With several clinicians involved, the administrative work adds up quickly. One portal holds the lab work. One office asks for the actual scan instead of the written report. Another needs the name and dose of a prescription from a different system. A referral may also sit in limbo until the patient notices that no one ever called.

Most people are managing this on top of work and family. A nonurgent lab or referral can disappear from the to-do list for months.

That is often how a six-month follow-up turns into a twelve-month one.

Better coordination doesn’t depend on every provider using the same software. Smaller workflow choices can close plenty of gaps. Schedule repeat testing before the patient leaves. Confirm that an outside report reached the chart. Before ordering a repeat test, check the recent record first. If a specialist is involved, the patient should also know whether that office or primary care is supposed to follow the result.

The last minute of the visit matters more than it sounds. “Come back if anything changes” doesn’t tell a patient whether anyone is expecting a repeat test, a call, or a return appointment. “Repeat this in six months, and our office will review the result with you” gives them a date, an action, and a clear owner.

AIHCP’s discussion of healthcare resource management is relevant here because wasted resources are not limited to budgets or staffing. Repeated tests, missing reports, and avoidable calls also use clinician time and patient time without necessarily improving care.

Care will still be spread across different places. A primary care office may use an outside lab, a hospital may handle imaging, and a specialist may keep a separate record. The practical question is whether the next clinician can see enough of that history to avoid starting over.

The patient shouldn’t have to rebuild that history from memory at every appointment.

Wrap-up takeaway

Preventive care starts to lose value when each appointment is treated as a separate event. Sometimes the test was done, but the result never made it back to the clinician who was supposed to act on it. Follow-up deserves as much attention as the screening itself. Patients can help by keeping copies of important reports and asking who is responsible for the next step, but the system still needs to do its share of the tracking. If several doctors are involved, it should be clear which office is watching each unresolved issue. Today, pull up your last physical or specialist note and check whether any repeat lab, referral, or screening was recommended without a date or a named person responsible for following it.

Author’s Bio

Ryan Harris writes about preventive health, longevity, and the changing role of diagnostics in modern healthcare. His work looks at how earlier risk detection, better health data, and more comprehensive assessments can help people make more informed decisions about their long-term health.

 

 

When the Hospital Is Hundreds of Miles Away: The Complexities of Medical Transport 

Speeding ambulanceWritten by Marchelle Abrahams,

The search for a missing air ambulance drew widespread news coverage over the weekend. A medical crew was reportedly transporting a patient and a family member from Bermuda to Boston when the plane went missing off the coast of Nantucket Island.

The unfortunate incident has left many questions unanswered, including how an aircraft could disappear moments after losing contact with air traffic control. 

And the 800-pound gorilla that hospital case managers are wondering about: transporting patients is a complicated web of safety and protocol. Where were the weak spots?

Answers remain vague, but that doesn’t discount the fact that medical transportation is a complex system that becomes even more intricate when the hospital is states away.

 

The Growing Need for Medical Transport

An aging population, rising rates of chronic illness, and a push to reduce missed medical appointments are part of the demand.

They’re also why the U.S. non-emergency medical transportation (NEMT) market is expected to grow to $13.43 billion by 2031, according to Research and Markets data.

NEMT providers serve Medicaid beneficiaries and patients in need of transportation to medical facilities for regular appointments and check-ups. Ambulance services, wheelchair assistance, stretcher services, flight services, and courier services are included.

However, working in healthcare gives us a bird’s-eye view of the challenges. Hospital case managers are probably the ones to witness this firsthand.

Inflation and operating costs leave many providers feeling squeezed, particularly in rural regions. The industry continues to face hurdles related to administrative complexity, broker dependencies, and compliance.

But we’re seeing some improvement. Strategy & Stats reports that collaborations among hospitals, private air medical transport companies, and insurers are improving coordination of patient transfer services and increasing access to air transportation services.

 

When Specialist Care Crosses State Lines 

Interstate medical transportation isn’t as cut-and-dry as transporting a patient and being done with it. Well, that’s what the general public thinks.

When it comes to medical transportation between states, providers must navigate a patchwork of federal rules, insurance policies, and operational scopes. There’s no single universal long-distance law dealing with interstate patient transport.

Hospital case managers and discharge planners usually handle the logistics of long-distance hospital transport. Discharge planning alone requires mountains of admin work. ACC Medlink suggests enlisting a professional, reliable transport partner that can provide documentation support.

 

The Role of Case Managers in Patient Transfers 

Nurse case managers are the unsung busy bees working behind the scenes. You ensure a patient’s transfer is safe, smooth, and continuous across care settings.

You evaluate the patient’s physical status, monitor vital signs, and decide whether the patient is stable enough for movement.

Probably your most underestimated role is advocating for your patient. You explain the inner workings of transferring them from one hospital to another facility and provide a vital link between them and their care team.

“During the 1960s and in subsequent decades, a growing patient rights movement embraced the importance of informed consent for honoring patients’ autonomy. Patient advocates arose as an important voice in this movement by educating patients about their rights and helping them participate more fully in decisions about their healthcare.” – Jennifer Schlinger, Clinical Associate Professor of Social Work, via The Conversation.

 

Access Barriers

Delayed care will remain a moot point as long as access to medical transport is only reserved for those who can afford it.

A 2024 review published in the Journal of Transport & Health paints a multifaceted picture. People in rural communities have to travel long distances to access healthcare services. The link between distance and/or travel time and healthcare service access hasn’t always been clear. 

The research looked at how distance and travel time affect access to healthcare for people living in rural and remote areas of developed countries. It found that travel time may be a better measure of healthcare access than distance, particularly for people living outside major cities.

 

FAQs

What is medical transportation between states?

Medical transportation between states refers to moving a patient across state lines to access healthcare. Depending on the patient’s condition, this can involve ground ambulances, non-emergency medical transportation, wheelchair or stretcher services, or medical flights.

Who arranges interstate medical transportation?

Hospital case managers, discharge planners, and healthcare teams often coordinate patient transfers. They may need to assess the patient’s medical needs, communicate with the receiving facility, arrange transportation, and ensure the necessary documentation is in place.

Why might a patient need to travel to another state for medical care?

Patients may need to cross state lines when specialized treatment is unavailable locally. This can include specialist consultations, advanced procedures, rehabilitation, transplant services, or treatment at a facility with specific expertise.

Is medical transportation between states covered by insurance?

Interstate medical transportation coverage depends on the patient’s insurance plan, medical needs, and the type of transportation required. Medicaid and private insurers may have specific eligibility and authorization requirements, so patients and care teams should confirm coverage before arranging transportation.

 

Medical Transportation: Key Stats 

Stat What it Tells Us
$13.43 billion Projected value of the U.S. non-emergency medical transportation market by 2031 
Travel time vs. distance Research suggests travel time may provide a better picture of healthcare access than distance alone
Cross-state transfers Interstate transfers can involve coordination between hospitals, insurers, transport providers, and healthcare professionals
Multiple transport options NEMT can include ambulances, wheelchair transport, stretcher services, medical flights, and courier services

 

Getting Patients There Is Part of the Care 

Healthcare doesn’t end when a patient leaves one hospital. Transporting them to the next facility is just as important. We may not know what happened on that fateful air ambulance flight.

But we do know it doesn’t define the NEMT industry. Yes, challenges remain top of mind, yet every case manager’s goal is to get patients from point A to point B with as few complications as possible.

Author bio

Writer by day, dream catcher by night. Marchelle Abrahams cut her teeth in the infancy of the internet when the dial-up sound of the modem was more than a soundbite at a rave. Not a Millennial and not a Boomer, Marchelle is an in-betweener, making her a special breed of human. As a qualified journalist, Marchelle believes her superpower is stringing a few words together and people reading them.

 

References:

Search suspended for missing Ontario-based air ambulance with four Canadians aboard : U.S. Coast Guard. (2026, October 5). Nationalpost. https://nationalpost.com/news/four-canadians-aboard-ontario-based-air-ambulance-missing-off-u-s-coast 

Ltd, R. a. M. (n.d.). US Non-Emergency Medical Transportation Market Size & Trends. Research and Markets Ltd 2026. https://www.researchandmarkets.com/report/united-states-non-emergency-medical-transportation-market 

Kardani, P. (2026, October 7). U.S. air ambulance services industry: emergency care insights. SNS Insider. https://www.snsinsider.com/blogs/air-ambulance-services-industry 

Schlinger, J. (n.d.). What is a professional patient advocate, and why might you need one? The Conversation. https://theconversation.com/what-is-a-professional-patient-advocate-and-why-might-you-need-one-281971 

Impact of distance and/or travel time on healthcare service access in rural and remote areas: A scoping review. Journal of Transport & Health July 2024. https://www.sciencedirect.com/science/article/pii/S2214140524000653 

Us, J. K. W. (2026, October 5). A surgeon shortage creates challenges in rural communities. The Week US. https://theweek.com/health/a-surgeon-shortage-creates-challenges-in-rural-communities 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

How Case Managers Connect the Pieces of Fragmented Healthcare 

African American medic shows medical test results on digital tablet computer to another doctor. Multicultural doctors discuss ways of treatment in middle of hospital corridor. Medical staff at work.Written by Deepika

No matter how diligently providers play their part, suboptimal care is a known outcome of a fragmented healthcare system. Consider the following scenario that is still commonplace: A patient is discharged with a new medication, a specialist referral, and follow-up instructions with primary care. 

The primary care provider receives part of the discharge information. At the same time, the specialist is working from a different set of records. Meanwhile, the patient is managing a chronic condition through another clinic, waiting for a referral appointment that has not been scheduled. 

Each provider is doing what they can, but nobody has the complete picture. This kind of fragmentation only becomes more complex when patients must navigate multiple parts of the healthcare system. 

In 2025, nearly 12.5 million people across the US were enrolled in both Medicare and Medicaid. Again, the two programs operate separately, with different eligibility requirements, benefits, and payment structures. The issue is ensuring that each provider has a shared understanding. 

Case managers can help create a connected process, and this article will explore how. 

 

Tracing Gaps in a Patient’s Care 

Before the fragmented pieces are connected, case managers need to know where those pieces are falling short. This means they would look beyond the immediate reason, be it a referral or recent hospitalization. Essentially, a patient’s larger care landscape would be assessed. 

If we go by recent research, a lot can be uncovered when care is examined across transitions. Take the example of a 2026 study involving 2,426 adults in a pharmacy-driven care transition program. It was discovered that 81.7% of the cases involved at least one medication error. 

Moreover, non-adherence to medication was noted in 45.6% of patients, along with barriers to accessing medication in 12.7% of cases. If a case manager were to fixate their judgment on a single encounter/record, they would not understand the real needs of the patient. 

A broader assessment would bring together information from medical records, the care team, and the patient. On a case-to-case basis, it’s important to look at the following:

  • Incomplete referrals: A recommended specialist or service has not been scheduled or received. 
  • Gaps in follow-ups: Instructions from one care setting have not been carried through to the next. 
  • Medication discrepancies: Medication lists, dosages, or treatment instructions that differ between providers. 
  • Duplicate services: Tests, assessments, or services may be recurring because providers lack visibility into what has already occurred. 
  • Unaddressed barriers: Transportation, cost, access, or other practical issues may make an otherwise relevant care plan challenging to follow. 
  • Missing information: Relevant records, test results, or treatment updates have not reached the provider who needs them. 

A September 2026 report by the American Medical Association on Ochsner Health’s hospital-to-home programs makes the practical importance of identifying such gaps much clearer. Ochsner had 293 patients with congestive heart failure enrolled in its acute care at home program in 2025. 

Although they represented 15% of the program’s home patients, they accounted for 16% of all reutilizations. In response, one of Ochsner’s strategic priorities for 2026 is to improve care coordination for this group. As Dr. Beau Raymond, the Chief Medical Officer for population health at Ochsner, stated, “We needed to be smarter about simple care coordination activities.” 

Also, keep in mind that Ochsner’s approach was not just about analyzing clinical information. It included identifying patients at risk, determining which home-based program fits their needs, and helping case managers navigate available options. Instead of documenting every detail of a patient’s journey, case managers should determine where the care pathway is most likely to break down. 

 

Building Bridges Across Providers and Care Settings 

After the gaps in a patient’s care have been identified, the next challenge is bringing the right people and services into the same care pathway. A case manager may have to coordinate communication between a primary care provider, specialist, hospital team, home health service, or a community-based resource. 

Each of these roles may differ, but that should not prevent the patient’s care from moving forward. The complexity of this coordination can vary depending on where and how a patient receives care. 

For instance, Community CareLink notes that distance and staffing make coordination critical in rural communities. Patients may have fewer healthcare providers nearby, requiring them to travel beyond their local community for certain services. 

The Health Resources and Services Administration (HRSA) notes that only 2% of residency training occurs in rural areas. Strengthening rural training will improve access to care and increase the likelihood that physicians practice in these communities. 

For rural health transformation, this can mean coordinating care that extends beyond its immediate network. A case manager may need to connect a patient with an outside specialist, help address scheduling barriers, and ensure the referring provider has all the necessary information. 

Essentially, several practical responsibilities form a part of this bridge-building process. These include the following:

  • Making sure each member of the care team has clear responsibilities 
  • Facilitating communication between professionals working from separate records 
  • Helping move a referral beyond the initial order by checking whether the patient reached the appropriate service 
  • Carrying relevant information and care responsibilities across settings such as hospitals, outpatient clinics, and community services 
  • Incorporating practical support, social services, and other community-based assistance into the broader care plan 

 

Turning Coordination Into Continuity of Care 

Connecting providers is only half of the work done. A patient can still experience a breakdown in their care if they do not receive a follow-up on the next steps. Continuity of care depends on whether the plan still works after those initial connections have been made. 

In other words, the focus of case management here is to keep the connected pieces together. Case managers can monitor whether recommended services were accessed, whether treatment plans are being followed, and whether new barriers have emerged. They also have the chance to analyze the patient’s needs amid changing circumstances. 

According to a recent CBS News feature, continuity of care becomes more difficult when local healthcare resources change. Sturgis Hospital in rural Michigan closed on June 19th, ending services that included surgery, medical imaging, physical therapy, and cardiac rehabilitation. 

The loss of its emergency department also meant that some patients who previously took an approximately 2-mile ambulance ride would now have to travel 25 miles. Situations like this show why continuity requires more than maintaining a list of referrals. Since a facility is no longer available, the patient’s care pathway may have to be rebuilt around what is accessible. 

Case managers play a significant role in that rebuilding process. Maintaining continuity of care may involve the following:

  • Confirming that referrals, appointments, and treatments happened promptly 
  • Watching for changes in the patient’s condition, circumstances, and ability to manage their care plan 
  • Adjusting coordination when a patient’s health or support needs change 
  • Ensuring important updates and responsibilities move with the patient from one stage of care to the next 

The Sturgis example also shows why continuity cannot be treated as a one-time task. The report noted that other clinics remained available after the hospital closed, but the emergency department’s absence left facilities in Three Rivers, Coldwater, and LaGrange, Indiana, as the closest alternatives to patients. 

A case manager can become a crucial link in such fragmentation. Instead of directing a patient to a new provider, they can look through the care plan again to see what has changed. That’s how it’s possible to ensure the next set of services still fit together. This type of attention to detail is particularly relevant in cases where the patient has multiple conditions or practical barriers to overcome. 

 

FAQs 

What problems do case managers help address in fragmented healthcare?

Case managers help identify gaps such as incomplete referrals, medication discrepancies, duplicate services, and practical barriers. They bring together information from different providers and settings to determine whether a patient’s care pathway is breaking down. 

How do case managers improve coordination between healthcare providers?

The way case managers improve coordination is by connecting care providers, facilitating information sharing, and helping carry care plans across different settings. This can be especially important when patients must travel for services or receive care from multiple organizations that do not work together. 

How do case managers help maintain continuity of care?

Case managers follow up after referrals and transitions, monitor changing needs, and adjust care coordination when circumstances change. If a provider or service becomes unavailable, they can help identify alternatives to ensure important information moves with the patient. 

 

Fragmented Healthcare At a Glance 

Care Challenge  Case Management Insight 
Scattered information  Find the missing pieces. 
Incomplete referrals  Follow the referral through.
Conflicting medication records  Reconcile the differences. 
Disconnected providers  Keep communication going.
Care across distant settings  Bridge the gaps between services.
Changing patient needs  Reassess the needs and adapt the care plan accordingly.
Loss of local services  Rebuild the care pathway. 
One-time coordination  Keep care connected.

Fragmentation in healthcare cannot be attributed to a single person or one failed interaction. It can develop when information is scattered across records and referrals lose their momentum. 

Case managers have the unique potential to make the system more connected. A 2026 randomized controlled trial involving 1,387 adults with multiple chronic conditions compared three approaches to case management after hospital discharge. 

While no considerable difference was observed in 90-day readmission rates, in-person care enabled patients to better understand and manage their care over the following year. Successful coordination cannot be determined by a single outcome. To keep a patient’s journey connected over time, multiple factors must be considered and addressed.

Author Bio

Deepika has over six years of experience as a writer and editor. Passionate about words and learning, she takes an interest in a variety of niches. Her knack for turning complex ideas into relatable narratives allows her to resonate with the reader. 

When her pen falls silent, you can find her engrossed in a novel or getting her hands messy with fine arts. Through these, Deepika is committed to keeping her curiosity and creativity alive. 

References:

  1. Centers for Medicare & Medicaid Services. July 2026. Medicare-Medicaid Coordination Office Fiscal Year 2025. 

https://www.cms.gov/files/document/mmco-report-congress.pdf-2

  1. Kevin McKeough. Better handoffs help home care cut hospital readmissions. American Medical Association. 

https://www.ama-assn.org/practice-management/payment-delivery-models/better-handoffs-help-home-care-cut-hospital

  1. Williams Kelly, et al. April 2026. Integrated care for chronic conditions: a randomized care management trial. PubMed. 

https://pubmed.ncbi.nlm.nih.gov/41838981/

  1. Rural Residency Planning and Development (RRPD) Program. September 2026. Health Resources & Services Administration. 

https://www.hrsa.gov/rural-health/grants/rural-health-research-policy/rrpd

 

 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

6 Doctor Quality Analytics Platforms Powering Value-Based Care in 2026

Stethoscope_and_keyboard_illustrating_concept_of_digital

Written by Cassandra Rosas

A doctor being “in-network” answers exactly one question: will the claim get paid. It says nothing about whether that doctor’s patients recover faster, avoid unnecessary procedures, or end up back in the emergency room three weeks later. For years, that gap didn’t matter much because nobody was measuring it at scale, but now a growing number of platforms are, and the results are reshaping how employers, health plans, and the case managers between them make referral decisions. Case managers, more than most people in the system, sit exactly at that intersection: clinically fluent enough to judge a referral, accountable enough for cost that a referral choice actually matters.

Commercial value-based arrangements grew from 34.6% of payments in 2022 to 39.2% in 2023, according to the HCP-LAN annual survey, conducted jointly with AHIP and BCBSA. That shift only works if someone can tell a high-value doctor from an average one, which is exactly the gap these six platforms are built to close. Garner Health tops this list because it’s built the furthest into that specific problem. The rest fill in adjacent pieces of the same puzzle.

What “doctor quality analytics” means for case managers

Ask 10 case managers what “in-network” means and most will describe a directory: a name, an address, a specialty code. Ask them what “high-quality” means for that same doctor and the answers get vague fast, because until recently there wasn’t much data to point to.

Doctor quality analytics platforms replace that vagueness with claims-based measurement: tracking things like complication rates, readmissions, and procedure volume at the individual physician level, then scoring providers against their peers in the same specialty and geography. For a case manager balancing a patient’s outcomes against a plan sponsor’s cost targets, that score is the difference between a referral made on convenience and one made on evidence.

This is the mechanical layer underneath the broader move toward value-based care, where a health plan gets paid, or penalized, based on outcomes rather than visit volume. You can’t manage what you can’t measure, and provider-level quality data is what makes that measurement possible below the plan level, down to the individual referral.

Consider a case manager referring a patient for a routine orthopedic procedure. Under the old model, the choice comes down to who’s in-network and who has an open slot. A quality-analytics model adds a layer: the case manager can see in advance whether one surgeon’s patients tend to need a second procedure within a year and others don’t. That’s the kind of signal that used to live only in a hospital’s internal peer review, if it was tracked at all.

How we selected these platforms

We looked for four things:

  • Claims-based quality data the platform built itself, not self-reported ratings
  • A product built for employers and health plans, not consumer directories
  • The ability to plug into existing navigation or benefits workflows without a rip-and-replace
  • Evidence, ideally quantified, that using the platform actually changes cost or outcomes

Six platforms cleared that bar, ranked here from the most quality-analytics-focused to the most complementary.

6 doctor quality analytics platforms to know in 2026

1. Garner Health

Garner Health built its entire product around one question: which doctors, specifically, produce better outcomes at lower cost? Its scoring engine runs claims data through more than 550 clinical metrics it built in-house, drawing on a database of over 60 billion medical records, to rank physicians within their own specialty and market. Employers use the results to reward employees for choosing top-performing doctors, usually by covering most or all of the resulting out-of-pocket costs, without narrowing the network or restricting anyone’s choice.

The approach appears to be working at a scale that’s hard to ignore. Garner reports that employers using its platform see an average 12% reduction in total healthcare spend in the first year, and employees who choose a high-performing provider pay roughly 80% less out of pocket than they otherwise would. The company closed a $100 million Series E at a $2.74 billion valuation in May 2026, just three months after a $118 million Series D, a pace of investment that reflects how much appetite employers have for this exact category.

2. Embold Health

Where Garner scores individual doctors, Embold Health has taken the model a step further and built a health plan around it. Embold Edge, launched in 2026, analyzes 21 specialties and 68 sub-specialties using data spanning more than 230 million people, then structures member copays to reward high-quality choices without requiring employers to disrupt their existing network or carrier relationships. Its underlying bet: most healthcare waste traces back to low-quality care at the start of a patient’s journey rather than overpricing further downstream, so fixing the first referral fixes a lot of what follows.

3. Ribbon Health

Ribbon Health operates further upstream from the case manager, supplying the provider data (insurance participation, cost estimates, quality scores, and patient experience) that other platforms and health plans build their own navigation tools on top of, rather than selling directly to members itself. If you’ve used a “find a doctor” tool from a health plan or a digital navigation vendor recently, there’s a reasonable chance Ribbon’s data powered it behind the scenes.

4. Included Health

Included Health bundles quality-based referrals into a much broader navigation and virtual care platform. Its Provider Connect feature routes members toward high-quality, cost-effective providers automatically as part of the standard member journey. Care coordination, virtual visits, benefits navigation, and referral steering all live in one product, rather than requiring a separate vendor for each.

5. Quantum Health

Quantum Health takes a similar bundled approach through its Care Finder tool, which surfaces provider search and quality data directly inside its broader healthcare navigation platform. For organizations that already route members through Quantum Health for case management and benefits navigation, Care Finder adds the quality layer without introducing a separate point solution.

6. Turquoise Health

Quality data only tells half the value-based care story. Turquoise Health fills in the other half: rate transparency and contract intelligence that show what providers are actually paid under negotiated agreements. Pairing that pricing data with a quality score from one of the platforms above gets closer to a true value calculation. A genuinely high-value doctor is one who scores well on outcomes and isn’t wildly overpriced relative to peers.

Choosing the right platform for your organization

The right fit depends on what you’re already running. Organizations with an existing navigation vendor that just want to layer in quality scoring are usually better served by a pure-play option like Garner Health or Embold Health. Organizations building navigation and referral management from scratch tend to gravitate toward a bundled platform like Included Health or Quantum Health instead. Vendors and health plans building their own tools look to infrastructure providers like Ribbon Health for the underlying data.

Turquoise Health belongs in the stack alongside any of the above, since cost transparency and quality analytics answer different questions. Worth asking before signing anything: how the platform’s data reaches the people making referral decisions day to day. A quality score buried in a quarterly report to HR doesn’t change a single referral. A quality score surfaced inside the tool a case manager already uses at the point of referral does, and that distinction matters more than any single feature comparison.

Frequently asked questions

What is doctor quality analytics?

Doctor quality analytics is the practice of measuring an individual physician’s performance, including complication rates and avoidable readmissions, using claims data, then scoring that physician against peers in the same specialty and market. It replaces network directories, which only confirm insurance participation, with an evidence-based answer to whether a specific doctor delivers better results.

How do case managers use provider quality data in referrals and care coordination?

Case managers use provider quality scores to steer referrals toward physicians with better documented outcomes, rather than relying solely on network status or personal familiarity. Combined with a patient’s specific clinical needs and plan design, quality data helps a case manager justify a referral choice on evidence, which matters increasingly as employers tie benefits design to demonstrated cost and outcome performance.

Do doctor quality platforms only work for large self-insured employers?

No, though large self-insured employers were the earliest and most visible adopters because they bear healthcare costs directly and can redesign benefits without an insurer’s approval. Health plans, associations, and mid-market employers now access the same underlying quality data through partnerships and smaller-scale deployments, so the category isn’t limited to the biggest balance sheets anymore.

 

Author bio

Cassandra Rosas is a content writer who loves to cover topics related to healthcare software and AI, employee benefits, and new healthcare trends emerging in the industry. In her spare time she enjoys hiking in the mountains and spending time outdoors.

 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Why Healthcare Professionals Should Follow Peptide Research

Scientists, male and female, work in research facilityWritten by Daniel Carter,

Healthcare keeps moving. New treatments arrive. Clinical guidance changes. Familiar therapies gain new uses. Peptides are part of this shift. Nearly 100 peptide medicines have now received approval worldwide. Insulin remains the best-known example. However, peptide therapy now reaches far beyond diabetes. Some medicines support cancer care. Others help manage pain. Peptides also play roles in bone health. They can support rare disease treatment and diagnostic imaging.

Why should healthcare professionals pay attention? Simple. Peptide research may affect prescribing and monitoring. It may also shape administration and patient education. Advanced chemistry training is not required. Still, professionals need a clear understanding of the evidence. In a changing field, continuing education matters. It helps clinicians recognize new benefits, risks, and limitations.

How are peptide medicines used across healthcare?

Peptides are short chains of amino acids. Proteins also contain amino acids. However, proteins are usually larger. They are also more complex.

Many natural peptides act as hormones. Others work as chemical messengers. Therapeutic peptides can copy these natural actions. Some block them. Others change a biological pathway’s response.

By 2022, more than 80 peptide medicines had entered global markets. Another 170 remained in clinical development. Global sales had passed $70 billion by 2019 (Wang et al., 2022).

Their clinical uses vary widely. Examples include:

  • Exenatide for type 2 diabetes care
  • Teriparatide for osteoporosis
  • Teduglutide for short bowel syndrome
  • Ziconotide for severe chronic pain

Other medicines serve different specialties. Enfuvirtide blocks HIV-1 entry into cells. Lutetium-177 dotatate targets certain neuroendocrine tumors.

These examples show an important point. Peptide treatment is not limited to one specialty. It can affect medication reviews in many clinical settings.

Healthcare professionals may encounter these medicines during routine care. A nurse may manage administration. A pharmacist may review interactions or storage. A case manager may coordinate follow-up care. Basic peptide knowledge can therefore improve team communication.

How is better design changing peptide drug development?

Peptide research once relied on slower laboratory methods. Modern design has changed that process. Solid-phase peptide synthesis is one major advance. It lets researchers build amino acid chains in sequence. The process is carefully controlled. Robert Bruce Merrifield developed the method while researching peptides. His work later earned the 1984 Nobel Prize in Chemistry.

Automation has improved the process further. Modern systems can increase speed. They can also improve accuracy and consistency. Researchers can now screen large peptide libraries. Each library may contain many possible candidates.

Small structural changes can also make a difference. One amino acid change may improve stability. It may also strengthen biological activity. Healthcare professionals can better assess treatment effects by understanding them at a practical level. Cyclization can make a peptide more rigid. Fatty-acid attachment may extend its activity. Liraglutide provides a clear example. It contains a C16 fatty-acid chain. A glutamic acid spacer connects the chain to the peptide. The result is longer activity (Wang et al., 2022).

These modifications affect more than laboratory performance. They may change dosing intervals. They can influence storage needs and treatment adherence. They may also affect how adverse reactions develop. Promising? Yes. Even so, every candidate needs careful clinical testing. Successful molecular design does not guarantee a useful medicine.

How is artificial intelligence changing peptide discovery?

Artificial intelligence can review huge amounts of peptide data. It can compare sequences and structures. It can also assess electrical charges. Possible target interactions can be studied too.

What can that achieve? Faster screening.

Some systems estimate binding strength. Others predict:

  • Toxicity
  • Solubility
  • Stability

Certain models can also create new peptide sequences. These sequences follow selected research goals. This process may help teams reject weaker candidates sooner. It may also reduce early development costs.

However, AI predictions are not clinical proof. Every model depends on its training data. Incomplete data can produce weak results. Biased datasets may create misleading patterns. An algorithm may identify a promising structure. However, it cannot prove that the structure will help patients.

Laboratory testing remains essential. Animal studies may follow. Human trials must then confirm:

  • Dosing
  • Safety
  • Effectiveness

AI can support discovery. It cannot replace evidence. Similar concerns shape the use of AI diagnostic tools across healthcare.

Healthcare professionals should keep this difference clear. Early research can sound impressive. However, it may still be far from clinical use.

Careful interpretation becomes especially important in public media. Patients may confuse computational promise with an available treatment.

Why is peptide delivery still so difficult?

Peptides often break down quickly inside the body. Digestive enzymes may damage them before absorption. Their size can also restrict movement across cell membranes. Electrical charge may create another barrier.

As a result, many peptide medicines still rely on injections (Xiao et al., 2025).

Researchers are studying other routes. Options include:

  • Nasal systems
  • Transdermal systems
  • Oral formulations
  • Extended-release formulations

Can oral peptide treatment work? Sometimes. Even then, absorption may remain low or inconsistent.

A formulation must protect the peptide during digestion. It must also support movement through the intestinal wall.

These challenges explain an important problem. A promising peptide may still lack a practical delivery method.

Delivery affects several areas of care:

  • Comfort
  • Storage
  • Adherence
  • Dosing frequency
  • Staff training

A new formulation may change the entire patient conversation. For example, extended release may reduce dosing frequency. However, it may create new storage needs. It may also require different monitoring.

Healthcare teams need to understand these tradeoffs. Only then can they advise patients clearly.

What are the main benefits and limits of peptide medicines?

Peptides attract attention because they can bind targets precisely. Their structures can also cover larger protein surfaces. Many small-molecule drugs cover smaller areas. That difference may matter clinically. Protein interactions may involve areas between 1,500 and 3,000 square angstroms. Small molecules often cover only 300 to 1,000 square angstroms (Wang et al., 2022).

This larger contact area may help peptides influence difficult protein interactions. Still, precision does not remove every limitation. Some peptides break down quickly. Others cannot cross cell membranes well.

Structural modification may also change their performance. Therefore, treatment benefits must be considered with practical barriers.

Certain products may require:

  • Refrigeration
  • Sterile preparation
  • Injection training

Safety also differs between products. GLP-1 receptor agonists commonly cause gastrointestinal effects.

Ziconotide requires intrathecal administration. It also needs neurological monitoring.

Is there one general peptide safety profile? No. Each product needs its own assessment.

That review should consider:

  • Its mechanism
  • Its delivery method
  • Its clinical evidence

Patient factors matter too. Kidney function may influence decisions. Liver function can also affect care. Other medicines require consideration. The patient’s treatment goals also matter. Healthcare professionals should avoid broad claims about peptide safety. Evidence for one product cannot automatically support another.

How could targeted peptide therapies change future care?

Peptides can help direct treatment toward selected receptors. They may carry:

  • Medicines
  • Imaging agents
  • Radioactive materials

Peptide-drug conjugates use this approach. They combine a targeting peptide with another treatment. Researchers are studying these systems extensively in cancer care. The DCTPep cancer database contained 6,214 peptide-related entries in 2024 (Sun et al., 2024).

Those records covered:

  • Approved therapies
  • Clinical candidates
  • Experimental sequences

Cell-penetrating peptides offer another approach. They may carry drugs into cells.

Some can transport genetic material. Others may carry nanoparticles. However, reliable tissue targeting remains difficult.

Peptides already support diagnosis too. Gallium-68 dotatate can identify certain neuroendocrine tumors. Lutetium-177 dotatate can then target the same receptor system. This pairing may improve patient selection. It may also support more focused treatment. This relationship combines diagnosis and therapy. It can show whether a tumor expresses the relevant receptor. Treatment may then target that same feature. However, these approaches need specialist imaging. They also require careful patient selection and coordinated follow-up.

How can regulatory knowledge protect patients?

Not every peptide product has the same regulatory status. That difference matters.

FDA-approved drugs undergo formal review. Regulators assess:

  • Safety
  • Effectiveness
  • Manufacturing quality

Investigational products follow another path. They remain within regulated research programs.

Compounded preparations follow separate requirements. However, they do not receive standard FDA premarket approval.

Some products carry the label “research use only.” These products are not approved for patient treatment.

Can online availability prove safety? No. A product may look professional. Yet it may lack dependable clinical evidence.

Healthcare professionals should first identify the exact product. They should also confirm the manufacturer.

Next, they should review:

  • The intended use
  • The dose
  • The regulatory status

Trial evidence deserves equal attention. Important details include:

  • Study phase
  • Participant numbers
  • Follow-up periods
  • Adverse events
  • Study endpoints

These decisions involve professional responsibility. Therefore, legal ethics in healthcare remain relevant. They matter when clinicians assess uncertain or unapproved products.

The FDA has highlighted several peptide-specific concerns:

  • Liver impairment
  • Drug interactions
  • QTc prolongation
  • Immunogenicity

These concerns do not apply equally to every product. However, they show why each therapy needs specific evaluation.

Regulatory awareness helps clinicians avoid unsupported assumptions. It also supports clearer documentation. Informed consent may become safer too (U.S. Food and Drug Administration, 2023).

How can peptide knowledge improve patient conversations?

Patients now encounter peptide claims in many places. Sources include:

  • Clinics
  • Social media
  • Product websites
  • Online sellers

Some promotions use appealing terms:

  • “Recovery”
  • “Wellness”
  • “Healthy aging”

These phrases may sound reassuring. However, they do not prove safety or effectiveness. Healthcare professionals need enough detail to explain the difference. Semaglutide has approved indications. It also has standardized formulations. Clinical trial data support its regulated uses.

A research chemical bought online may offer none of those protections.

Medication reviews should include:

  • Injections
  • Compounded products
  • Online purchases

Clinicians should record:

  • The product name
  • The dose
  • The source
  • The patient’s treatment goal

In practice, careful medication planning for patients can reveal duplication. It can also identify unsafe combinations or unclear goals.

Teams should watch for duplicate therapies. Similar products may affect the same receptors.

Clear communication can reduce confusion. It may improve monitoring. It can also prevent avoidable harm. Professionals should explain what is known. They should also explain what remains uncertain. Product quality matters too. This approach respects patient interest. It does not validate unsupported claims. These conversations may involve several healthcare roles. Pharmacists can review formulations and interactions. Nurses may identify administration problems. Case managers may notice access or adherence barriers. Shared information helps the entire team respond consistently.

Why does staying current matter for responsible care?

Peptide medicines already influence many areas of healthcare. They support diabetes treatment. They also help with cancer imaging. Some products support pain management. Others address bone loss or rare diseases. Meanwhile, the field keeps expanding. New delivery systems are emerging. AI tools are supporting discovery. Targeted therapies are also becoming more advanced. Understanding advances in peptide science supports stronger clinical judgment. It helps professionals interpret new evidence. It also helps them avoid overstating findings. Current knowledge supports safer monitoring. It also leads to clearer patient conversations.

 

 

Author bio

Daniel Carter is a health and science writer. He covers clinical research, medical innovation, and patient education. His work makes complex healthcare topics clear for professional audiences. Outside of writing, Daniel enjoys hiking, reading history, and cooking for family and friends.

 

References

American Institute of Health Care Professionals. (2024, March 14). Case manager’s role in medication planning for patients. https://aihcp.net/2024/03/14/case-managers-role-in-medication-planning-for-patients/

American Institute of Health Care Professionals. (2025, January 10). The role of legal ethics in healthcare. https://aihcp.net/2025/01/10/the-role-of-legal-ethics-in-healthcare/

American Institute of Health Care Professionals. (2025, February 25). Lifelong learning in healthcare: Why continuing education matters. https://aihcp.net/2025/02/25/lifelong-learning-in-healthcare-why-continuing-education-matters/

American Institute of Health Care Professionals. (2025, July 1). Emerging trends in AI diagnostic tools shaping the future of accessible healthcare. https://aihcp.net/2025/07/01/emerging-trends-in-ai-diagnostic-tools-shaping-the-future-of-accessible-healthcare/

Sun, X., Liu, Y., Ma, T., Zhu, N., Lao, X., et al. (2024). DCTPep, the data of cancer therapy peptides. Scientific Data, 11, Article 541. https://doi.org/10.1038/s41597-024-03388-9

U.S. Food and Drug Administration. (2023, December). Clinical pharmacology considerations for peptide drug products: Draft guidance for industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-pharmacology-considerations-peptide-drug-products

Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: Current applications and future directions. Signal Transduction and Targeted Therapy, 7, Article 48. https://doi.org/10.1038/s41392-022-00904-4

Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025). Advance in peptide-based drug development: Delivery platforms, therapeutics and vaccines. Signal Transduction and Targeted Therapy, 10, Article 74. https://doi.org/10.1038/s41392-024-02107-5

 

 

 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

How Revenue Cycle Management Shapes the Care You Can Actually Deliver

photo of a health care professional man in blue scrubs holding an I pad and touching the screen with an overlay of white color iconsWritten by Isaac Smith

A physician spends over a decade training to treat patients, not to process claims. She opens a multi-specialty practice with an in-house lab, the one she’s proudest of, the one that was supposed to be the easy win. Six months in, she’s on hold with a payer on a Saturday morning instead of at her kid’s soccer game. Again.

The lab was supposed to be the easy win. Faster results, better continuity of care, one less referral to chase down. Nobody warned her that lab claims come with their own dense rulebook: bundled panels, frequency limits, medical necessity documentation that has to match almost exactly what the payer expects to see. Get one piece wrong and the whole claim bounces back.

This isn’t really a story about one doctor. It’s the story of almost every clinician who’s ever tried to run a practice.

Nobody Trains You for This Part

Nursing school teaches you to read a chart. Case Management Certification teaches you to coordinate care across a dozen moving pieces at once. Counseling programs teach empathy, boundaries, and clinical judgment. None of it, not one hour of it, in most programs covers what happens after the visit ends, once the claim gets submitted and somebody, somewhere, decides whether it gets paid.

That gap is forgivable in a classroom. It’s a lot less forgivable once real patients are involved. A denied claim isn’t just an accounting headache. It can hold up a follow-up test a patient actually needs. A credentialing application stuck in review for eight weeks means a new provider is sitting there fully licensed, willing to work, and unable to see anyone because the paperwork with a payer hasn’t cleared yet. It happens more often than people outside of billing tend to realize.

Where Things Go Wrong, and Why Lab Claims Are Their Own Animal

Most denials aren’t about bad medicine. They’re about a missing modifier. An eligibility checks nobody ran before the appointment. A diagnosis code that’s close but not quite what the payer wanted.

Lab billing takes all of that and multiplies it. There’s a reason so many practices that run their own labs, or order a high volume of diagnostic testing, end up looking at outsourced lab billing services instead of trying to build that expertise in-house — the rules shift often enough, and the denial rate on lab claims handled by a generalist billing team tends to run noticeably higher than routine office visit claims. It’s a narrow enough specialty that most practices are better off bringing in people who already live in it every day, rather than learning it the expensive way, one denied claim at a time.

Denial management itself is often treated as a one-off task rather than an actual process. Someone clears today’s stack of denials and moves on to the next fire. Nobody goes back and asks why the same error keeps showing up month after month. That’s usually where the real money quietly leaks out, and where practices lose the most without ever quite noticing it.

Why Clinicians Should Care About Any of This

Nobody’s saying a nurse practitioner needs to learn CPT coding cold, or that a case manager should be reading payer contracts for fun on a Friday night. But understanding just enough to know when something’s off is a different skill entirely, and it’s one that actually protects patients.

The practices that hold onto good staff, and that don’t lose patients to administrative delays, tend to share one thing in common: someone is paying attention to this side of the operation before it turns into a five-alarm fire. Sometimes that’s the physician herself, squeezing it in between patients. More often, it’s a billing partner who’s already seen the same problem a hundred times before and knows exactly where it’s headed.

Credentialing: The Quiet Bottleneck

It’s worth pausing on credentialing specifically, because it’s easy to underestimate. A practice hires a great new provider, expects them to start seeing patients right away, and doesn’t realize that payer credentialing can take anywhere from a few weeks to several months depending on the plan. In the meantime, that provider is either sitting underused, or the practice starts billing under someone else’s name and creates a compliance headache down the road. Getting ahead of credentialing early, before the hire even starts, saves more revenue than most practices realize until they’ve lived through the alternative.

The Bottom Line

Clinical skill is what gets a patient through the door. Whether they keep coming back, whether the provider who treated them actually gets paid on time, whether the practice is even still standing a year from now, depends on something a lot less visible than the chart itself.

If you’ve lived this, as a provider, a case manager, or whoever ends up fielding the billing calls nobody else wants to take, you already know it’s real. It’s one of the most overlooked pieces of whether good care actually reaches the people who need it, when they need it most.

Author Bio: Isaac Smith is a revenue cycle management (RCM) content writer with a background in journalism and a passion for healthcare and finance. With over a decade of experience creating informative and engaging content, he specializes in topics related to medical billing, coding, revenue cycle management, compliance, reimbursement trends, healthcare technology, and financial optimization. As a content writer at Manifest Technology Solutions, a leading medical billing and RCM services company, Issac develops insightful content that helps healthcare providers, medical practices, and billing professionals navigate the evolving healthcare landscape. His goal is to simplify complex industry concepts, share practical strategies, and support organizations in improving operational efficiency and financial performance.

 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

How Case Managers Can Help Patients Avoid Predatory Treatment Programs 

case managers working at a tableWritten by Marchelle Abrahams,

A typical day for Oklahoma City case manager Joe Aitson involves getting people placed in evidence-based treatment programs.

His life could have gone in a completely different direction. Describing his former “criminal mentality,” Aitson tells NPR that his introduction to drugs started when he was a teenager.

Thanks to his recovery, Aitson has found meaning in his addiction. Now he uses his lived experience to help others navigate an already complicated system.

The recovery navigator knows that finding addiction treatment should not be overwhelming and leave you defeated. And yet, for many patients and families, that’s exactly what happens.

Searching in a moment of urgency, they make decisions on the fly. When every website claims to offer “comprehensive care,” it becomes hard to tell what’s real and what’s marketing fluff.

That’s where individuals like Joe Aitson take their roles as case managers seriously. They act not as a coordinator, but as a filter. An advocate. And sometimes the only line of defense between a patient and a bad placement.

A case manager’s role is rarely small. Done well, it can change the entire trajectory of someone’s recovery.

 

The System Patients Are Walking Into 

Most patients don’t enter treatment with a reasonable understanding of how the system works. They’re trying to solve an immediate problem. Stop using. Stabilize. Get help. The details come later, if at all.

The treatment landscape is crowded. Some programs are solid and clinically grounded. Others are not. Investigative journalist and author Shoshona Walter shared firsthand accounts in her book Rehab: An American Scandal.

In it, she points out the same issues over again: aggressive marketing, unclear pricing, and admissions processes that are more like sales calls than clinical assessments.

Then there are policy gaps. A recent opinion piece by Helen King discusses how some states still lag in protecting patients from questionable insurance practices.

In simple terms, patients are being asked to make high-stakes decisions in a system that isn’t always transparent. 

 

Why Case Management Carries So Much Weight 

Case management comprises coordination. In addiction care, it provides protection. 

Case managers ensure that the right level of care is provided to the patients. They also keep an eye on key factors such as housing, employment, mental health, and family dynamics.

That sounds straightforward. But it takes work to slow things down in an environment built around speed.

Red Flags That Should Be Watched

Sometimes, the warning signs manifest early. The problem is spotting them too late, and only after a placement is made.

The Sales Pitch

Patients are told what they want to hear. A quick admission. Promises of tailored care without a proper assessment. 

Now that’s a problem. 

Legitimate addiction treatment centers should understand the patient, not fill a bed.

 

Letting the Amenities Be the Hero

While comfort is important, there are more things to take care of. When the focus is on “resort-style living” and “five-star amenities”, that’s when you ask what’s happening clinically behind the scenes. Treatment is not the same as a comfortable stay.

 

Billing That Doesn’t Add Up 

Some programs rely heavily on frequent testing or extended stays with little justification. Patients don’t always see this directly. It does, however, show up in how care is structured. 

 

Weak Discharge Planning 

What happens after treatment is not an afterthought. It’s part of the treatment. Programs that lack a path forward leave patients exposed at a vulnerable point in their lives.

 

What Case Managers Can Do

Avoiding bad programs is one part of the job. The other is actively steering patients toward reputable rehab centers.

Start With a Real Assessment

This sounds basic, and yet it’s frequently rushed. 

A solid assessment looks beyond substance use. It includes mental health, living situation, employment, and support systems. Without context, it’s easy to match a patient to the wrong level of care.

 Programs that take this seriously tend to build more effective treatment plans. 

Focus on Evidence, Not Promises 

Holistic. Comprehensive. Personalized. Some of it is meaningful. Some of it is not. 

Case managers should concentrate on a facility’s track record. Southern California has consistently ranked among the most successful rehab hubs. It also has the highest concentration of treatment facilities. Malibu, Orange County, and the Coachella Valley are home to trusted treatment programs in Southern California. Look for:

  • Access to medication-assisted treatment when appropriate
  • Individual therapy
  • Mental health support
  • Structured relapse prevention

South Shores Recovery says that trusted addiction treatment programs offer medically supervised detox programs alongside inpatient rehab.

Check Who is Delivering the Care

Patients should have access to licensed counselors, social workers, and medical professionals. A rotating cast of minimally trained staff is not the same thing.

Outcomes tend to improve when multidisciplinary teams are involved because they look beyond the presenting problem.

Ask Direct Questions

And expect direct answers:

  • How often does the patient meet with a clinician?
  • How is progress measured during the treatment process?

 

Keep the Focus on Independence 

It’s easy for organizations to create dependency. A good case manager does the opposite.

The goal is not to complete a program. It’s to help the patient function outside of it. That includes practical things (housing, work, daily structure) that don’t always get enough attention.

The Case Management Society of America emphasizes these factors as a move toward independence as a core responsibility.

 

FAQs

1. What is the clearest sign of a predatory treatment program?

A sales-driven intake process without a proper clinical assessment is one of the strongest warning signs.

2. How can case managers verify a program’s quality?

Reviewing staff credentials is the first step. Case managers should also ask for detailed treatment schedules. Additionally, they must confirm the use of evidence-based therapies.

3. What should happen after treatment ends?

Patients should leave with an aftercare plan that includes housing, support services, and ongoing recovery resources.

Key Findings

Finding Source
Coordinated care improves outcomes in substance use treatment  NCBI Bookshelf 
Case management improves service access and continuity of care  Rural Health Information Hub 
Some states still lack protections against predatory insurance practices  Opinion piece on PennLive
Long-term recovery is strongly tied to social and economic stability  The New Republic 

 

Addressing Bigger Issues

Some challenges are unfortunately bigger than treatment programs. These include problems around access to medication-assisted treatment and long-term recovery support.

There are a few crucial questions that need to be answered. What if people were paid to stop using drugs? It also discussed financial stability and incentives for recovery outcomes.

Case managers cannot fix systemic issues alone, but they can advocate for resources that support recovery beyond treatment.

 

Author bio

Writer by day, dream catcher by night. Marchelle Abrahams cut her teeth during the infancy of the internet when the dial-up sound of the modem was more than a soundbite at a rave. Not a Millennial and not a Boomer, Marchelle is an in-betweener, making her a special breed of human. As a qualified journalist, Marchelle believes her superpower is stringing a few words together and people reading them. That, and the ability to take her kids on with her unique brand of gnarly comebacks. 

 

 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

A Case Manager’s Guide to Social Determinants in Addiction Care 

Case Manager helping a patient

Written by Marchelle Abrahams

Interruptions to addiction treatment could make it harder to recover. No one knows this better than case manager Annette Hubbard. Working at a local community clinic in Alaska, she’s seen thousands of patients come and go.

The majority of her clients are in and out of prison. They are the most vulnerable to drug-related deaths. Hubbard routinely checks the court docket for active warrants. She helps those with opioid use disorder get treatment before they go in. 

Hubbard tells NRP that she does it voluntarily, even though it’s outside her scope of work. Because she knows that addiction doesn’t happen in a vacuum. Neither does recovery.

If you’re a case manager, you already know this. A treatment plan can look perfect on paper and fail in the real world. Why? Simple. Social determinants of health (SDOH) influence outcomes long before a client walks through your door.

This guide breaks it down in plain terms: what SDOH means in addiction care, where case managers fit in, and how to turn awareness into action.

 

What Are Social Determinants of Health? 

These are the conditions in which people live. Work in. Move through everyday life. Housing, income, education, access to care, and social support; these are all SDOH.

These factors have a bigger impact on health outcomes than medical care alone. That’s not a small claim. It reshapes how we think about addiction treatment, explains the CDC.

The Healthy People 2030 framework groups SDOH into five key areas:

  • Economic stability
  • Education access and quality
  • Healthcare access and quality
  • Neighborhood and built environment
  • Social and community context

Case managers view the above as daily barriers.

 

How SDOH Fits into Addiction Care

Substance use disorders (SUDs) are linked to life conditions. Housing instability. Unemployment. Trauma. Lack of access to care. They all raise risk.

The American Journal of Psychiatry published a paper earlier this year. The piece explored the intersection between the Diagnostic and Statistical Manual of Mental Disorders (DSM) and SCE-DoH.

Researchers found that:

  • People without stable housing struggle to stay in treatment.
  • Limited income restricts admission for ongoing care.
  • Social isolation increases relapse risk.
  • Poor access to services delays intervention.

The National Academy of Medicine supports these outcomes and has called for a move towards integrated systems that address clinical care and social needs. In other words, treat the person, not only the addiction.

 

The Case Manager’s Role

Case managers sit at the crossroads of addiction and recovery care. Clinical teams, social services, families, and community resources all run through you.

Effective case management improves engagement, continuity of care, and long-term outcomes. And it goes beyond paperwork and scheduling. It’s your job to identify social barriers, connect clients to resources, and advocate across networks.

Think of it this way: clinicians stabilize. Case managers sustain.

 

Breaking Down Key Social Determinants

Housing Stability

Housing is one of the strongest predictors of recovery success. Back in 2024, Delaware’s Department of Health and Social Services put the hypothesis into practice.

Homelessness is common for those struggling with addiction, said Joanna Champney, director of the Division of Substance Abuse and Mental Health. 

“Reports from our behavioral health treatment providers indicate that when people enter mental health treatment in Delaware, 13% were totally homeless at admission. For people entering addiction treatment in Delaware, 7% were totally homeless.” – Joanna Champney via WHYY.

Using 2023 data, Champney reported that 67% of clients receiving services through the federal Statewide Opioid Response Grant experienced housing instability. The DHSS then initiated the Recovery Support Scholarship program, allowing treatment centers to provide housing support for patients.

As a case manager, you can:

  • Prioritize housing referrals early
  • Work with transitional housing programs
  • Build relationships with local shelters and housing services

Economic Stability

Treatments cost money. So does time off work. Unfortunately, not all rehab facilities accept Medicaid coverage. 

New Mexico’s Albuquerque is rife with fentanyl addiction. The city’s Bernalillo County Metropolitan Detention Center is currently struggling with inmates battling drug addiction. Most are forced to detox while in prison.

Fentanyl remains the top drug threat in the area, particularly among young people, claims the DEA. Albuquerque programs that take Medicaid plans are a lifeline for residents. 

Medicaid-covered rehab can open doors to detox, in-patient, and out-patient care. Financial stress is a relapse trigger. Reducing it is part of the treatment. 

Albuquerque Medicaid treatment programs provide essential support for individuals who cannot afford private insurance, adds Icarus Recovery Center. Focus on:

  • Verifying insurance early
  • Educating clients on coverage
  • Identifying low-cost or no-cost options

Healthcare Access

Access is not having a clinic nearby. It entails getting in, staying in, and being treated.

And yet, the National Library of Medicine says that gaps in care remain an issue. It disrupts recovery during the transition period. Once again, this is where you step in.

Case managers should prioritize coordinating appointments across providers, reducing wait times where possible, and supporting follow-ups.

Social Support and Community

Recovery is hard to sustain.

Isolation and loneliness can trigger relapse. Support networks improve outcomes; it’s that simple.

Research published in Frontiers in Rehabilitation Science supports the suggestion of community integration in long-term recovery.

What works?

  • Peer support groups
  • Family engagement
  • Community-based recovery programs

 

Common Gaps Case Managers Should Be Aware Of

Even experienced professionals tend to miss a few things. Here are a few to keep on your radar:

  • Transportation gaps: Missed appointments can trace back to travel issues
  • Digital access: Telehealth fails without stable internet or devices
  • Childcare needs: Specifically in outpatient settings
  • Legal issues: Court dates and compliance requirements disrupt care

None of these sit inside treatment plans. But they do determine outcomes.

 

FAQs

1. Why are social determinants important in addiction recovery?

They directly affect whether someone can start, continue, and complete treatment. Clinical care alone isn’t enough.

2. What is the most critical SDOH in addiction care?

Housing is the biggest factor. Without stability, recovery outcomes drop substantially.

3. How can case managers improve access to care?

By coordinating services, reducing barriers such as cost and transport, and connecting clients to community resources.

4. Do Medicaid programs improve treatment outcomes?

Yes. They expand access to care for low-income individuals, making treatment more consistent and achievable.

 

Key Stats on SDOH and Addiction Care 

 

Factor Insight Source
SDOH impact Social factors can influence the majority of health outcomes CDC
Housing and addiction 7% were totally homeless WHYY
Housing instability 67% of clients The Division of Substance Abuse and Mental Health
Medicaid access Expands availability of detox and rehab services Icarus Recovery Center

 

From Awareness to Action

Understanding SDOH is the first step. Acting on them is where you’ll make the biggest impact.

Ask better intake questions. Map local resources. Track barriers over time. Advocate for system-level changes.

You don’t need to fix everything, but you do need to notice everything. And that’s the difference.

 

Author bio:

Writer by day, dream catcher by night. Marchelle Abrahams cut her teeth during the infancy of the internet when the dial sound of the modem was more than a soundbite at a rave. Not a Millennial and not a Boomer, Marchelle is an in-betweener, making her a special breed of human. As a qualified journalist, Marchelle believes her superpower is stringing a few words together and people reading them. That, and the ability to take her kids on with her unique brand of gnarly comebacks.

 

 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

How Early Intervention Services Can Improve Long-Term Patient Outcomes

leadership in healthcare, doctors applauding successWritten by Amanda Collins,

There is a principle that underpins some of the most clinically defensible approaches in modern healthcare, and it is straightforward to articulate but persistently difficult to operationalize: identifying and treating a condition during its earliest phase produces outcomes that later-stage intervention rarely matches. Most healthcare professionals accept this intellectually without much debate. The challenge lies not in the concept itself but in the structural, systemic, and resource-related barriers that prevent early intervention from being consistently realized across patient populations and clinical settings.

The evidence base supporting early intervention has matured considerably across multiple specialties. What was once a principled argument grounded primarily in biological theory now carries the weight of longitudinal studies, randomized controlled trials, and meta-analyses spanning neurodevelopmental disorders, chronic disease management, and behavioral health. The cumulative picture is compelling: timely, appropriately designed intervention modifies disease trajectories in ways that alter not only immediate clinical indicators but life-course outcomes for patients across the age spectrum (Shonkoff et al., 2012).

Neural Plasticity and the Developmental Window

The neurobiological rationale for early intervention is perhaps most clearly articulated in pediatric contexts, where the concept of sensitive periods in development has been extensively studied. The early years of life represent a phase of extraordinary synaptic density and neural reorganization, during which the brain demonstrates a degree of plasticity that declines progressively with age (Knudsen, 2004). Structured therapeutic input delivered during this window has the capacity to redirect developmental trajectories in ways that become increasingly difficult to achieve once these periods have closed.

In the context of autism spectrum disorder (ASD), this principle has direct clinical relevance. Children diagnosed early and enrolled in evidence-based intervention programs before the age of four consistently demonstrate stronger gains in cognitive functioning, adaptive behavior, language acquisition, and social communication than those who begin intervention later (Dawson et al., 2010; Zwaigenbaum et al., 2015). Applied Behavior Analysis (ABA), the Early Start Denver Model (ESDM), and naturalistic developmental behavioral interventions (NDBIs) represent the most rigorously evaluated approaches within this space, each demonstrating meaningful effect sizes when delivered with appropriate intensity and clinical fidelity.

The practical implication of this evidence is that access to intervention matters as much as the quality of the intervention itself. Organizations such as BlueSprig Autism centers have developed multi-site models designed specifically to address the access gap, recognizing that geographic distribution and waitlist reduction are not merely logistical concerns but clinical priorities with measurable consequences for patient outcomes. A child who waits twelve months for a therapy placement after diagnosis loses twelve months of intervention during a developmental window that cannot be recovered.

It is also important to note that the neuroplasticity argument is not confined to pediatric populations. Emerging research in adult neuroplasticity has demonstrated that the brain retains meaningful capacity for functional reorganization well into adulthood, particularly in the context of structured rehabilitation following neurological injury, and during the early phases of psychiatric conditions when intervention can prevent the consolidation of maladaptive patterns (Cramer et al., 2011).

The Economic and Clinical Case Against Delay

From a health economics perspective, the cost of delayed intervention is rarely calculated in a way that reflects its true magnitude. Healthcare systems tend to measure cost in terms of current expenditure rather than future liability, which systematically undervalues preventive and early-stage services while underestimating the long-term costs of conditions that progress untreated.

Research in chronic disease management has consistently demonstrated that early, coordinated care reduces downstream utilization. Patients with pre-diabetes who receive structured lifestyle intervention, regular monitoring, and timely pharmacological support when indicated show significantly lower rates of progression to type 2 diabetes than those managed with advice alone (Knowler et al., 2002). Patients with early-stage heart failure enrolled in proactive case management programs demonstrate reduced rates of acute decompensation and hospital readmission compared with those receiving standard follow-up (Feltner et al., 2014). These are not marginal differences. They represent measurable reductions in morbidity, improvements in functional status, and cost savings that compound over time.

The role of coordinated care in facilitating early intervention deserves particular attention. Effective healthcare case management functions as the operational mechanism through which early warning signs are identified, acted upon, and tracked longitudinally. When case managers are embedded in care pathways from the point of initial presentation, the probability that a deteriorating patient receives timely clinical attention increases substantially. The evidence from both inpatient and community settings supports this: structured case management is associated with earlier identification of clinical deterioration, more consistent adherence to evidence-based treatment protocols, and reductions in preventable adverse events (Stanton & Dunkin, 2018).

Behavioral Health and the Cost of Diagnostic Delay

The consequences of delayed intervention are particularly well-documented in behavioral health, where the gap between symptom onset and diagnosis and treatment is often measured not in months but in years. The median delay between the onset of a mental health condition and first treatment contact has been estimated at between eight and twelve years across major diagnostic categories, including depression, anxiety disorders, and psychotic spectrum conditions (Wang et al., 2005). This delay is not clinically inconsequential. Extended periods of untreated psychopathology are associated with syndromic progression, development of comorbid conditions, erosion of occupational and social functioning, and reduced responsiveness to treatment at the point of eventual intervention (McGorry et al., 2008).

Early psychosis intervention programs developed across Australia, the United Kingdom, and North America have demonstrated that coordinated, multi-element intervention delivered during the early phase of psychotic illness produces superior functional outcomes compared with standard care, with gains in employment, social integration, and relapse prevention that persist at five-year follow-up (Kane et al., 2016). The RAISE study in the United States provided landmark evidence that coordinated specialty care for first-episode psychosis produces measurable and clinically significant advantages over treatment as usual, particularly when initiated within the first two years of illness onset.

The implications for system design are clear: behavioral health services that are structured around early access rather than crisis response produce better outcomes at lower long-term cost. The emphasis on patient outcomes in home care reflects this understanding, recognizing that proactive monitoring and regular contact between patients and clinical teams can identify early markers of relapse or deterioration before they reach the threshold of acute presentation.

Digital Care Pathways and the Expansion of Early Access

One of the more significant structural changes in healthcare delivery over the past decade has been the emergence of digital and telehealth platforms that reduce the logistical barriers to early clinical contact. Access delay has historically been one of the primary mechanisms through which early intervention fails in practice. A patient who develops a concerning symptom but cannot secure an appointment for several weeks, or who lives at considerable distance from specialist services, effectively operates outside the early intervention window regardless of how well-designed the services themselves may be.

Telehealth platforms and digital care pathways have meaningfully altered this dynamic for a growing subset of the patient population. Services delivered through an online medical clinic model allow patients to initiate clinical contact at the point of concern rather than at the point of appointment availability, enabling earlier access to assessment, prescription management, and onward referral. The clinical literature on telehealth broadly supports its utility for chronic disease management, mental health, and preventive care, with evidence demonstrating comparable outcomes to in-person care for a range of conditions when appropriate clinical protocols are maintained (Dorsey & Topol, 2016).

The value of digital access is not that it replaces relationship-based, longitudinal care, which remains the foundation of the best clinical outcomes, but that it addresses the temporal gap between identification and intervention. In the context of early intervention specifically, this gap is the critical variable. Platforms that reduce it serve a genuine clinical function, not merely a convenience one.

Systems-Level Barriers and the Need for Structural Reform

Understanding why early intervention underperforms relative to its evidence base requires an honest examination of the structural factors that impede it. Fee-for-service reimbursement models create incentives oriented toward volume and acute care rather than prevention and early-stage management. Specialist waiting lists generated by supply-demand imbalance convert timely referrals into delayed appointments. Fragmented health record systems prevent the communication of early warning signs across care settings. These are system design problems, not individual clinician failures, and they require system-level solutions.

The growing body of research on disease management programs illustrates what structured, longitudinal care coordination can achieve when these barriers are reduced. Disease management frameworks replace the episodic encounter model with a continuous monitoring approach in which patients with established or emerging chronic conditions are actively followed rather than passively awaiting deterioration. The outcome data from well-implemented programs are consistent: reduced emergency department utilization, lower rates of preventable hospitalization, improved adherence to evidence-based treatment protocols, and measurable improvement in patient-reported quality of life (Bodenheimer et al., 2002).

The professional development of healthcare teams represents an equally important component of effective early intervention infrastructure. Clinicians who possess advanced competencies in screening, risk stratification, and care coordination are better positioned to identify and act on early clinical signals. Certification programs that develop these competencies serve a meaningful population health function, extending the system’s capacity to intervene at the right moment across a broader range of clinical contexts.

Translating Evidence Into Practice

The gap between what the evidence recommends and what clinical systems routinely deliver is not a new observation. Implementation science has established that the translation of research findings into consistent clinical practice is itself a complex, multi-factorial challenge that requires sustained investment in training, workflow redesign, and performance monitoring (Fixsen et al., 2005). For early intervention specifically, implementation fidelity matters considerably. A program that is evidence-based in design but poorly executed in practice does not produce the outcomes that the evidence predicts.

What the accumulated research across neurodevelopmental conditions, chronic disease, and behavioral health ultimately demonstrates is that the timing of intervention is itself a clinical variable, one that is modifiable and that carries measurable consequences for long-term patient outcomes. Healthcare systems that treat early intervention as a scheduling preference rather than a clinical priority will continue to generate the downstream costs, in human terms as well as economic ones, that effective early intervention is specifically designed to prevent.

Redesigning care pathways to prioritize timely access, equipping clinical teams with the competencies to identify and act on early presentations, and building coordination structures that maintain continuity across the episode of care are not aspirational goals. They are the operational requirements of a healthcare system genuinely committed to the outcomes its evidence base says are achievable.

About the Author

Amanda Collins is a healthcare writer and patient advocacy specialist with over a decade of experience covering clinical practice, care coordination, and health system design. Her work focuses on translating complex health policy and research into rigorous, evidence-informed content for clinical professionals. Amanda has contributed to a range of professional health publications and holds a particular interest in neurodevelopmental intervention, chronic disease management, and the structural determinants of healthcare quality.

 

References

Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002). Improving primary care for patients with chronic illness: The chronic care model, part 2. JAMA, 288(15), 1909–1914.

Cramer, S. C., Sur, M., Dobkin, B. H., O’Brien, C., Sanger, T. D., Trojanowski, J. Q., & Bhatt, D. L. (2011). Harnessing neuroplasticity for clinical applications. Brain, 134(6), 1591–1609.

Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., Donaldson, A., & Varley, J. (2010). Randomized, controlled trial of an intervention for toddlers with autism: The Early Start Denver Model. Pediatrics, 125(1), e17–e23.

Dorsey, E. R., & Topol, E. J. (2016). State of telehealth. New England Journal of Medicine, 375(2), 154–161.

Feltner, C., Jones, C. D., Cené, C. W., Zheng, Z. J., Sueta, C. A., Coker-Schwimmer, E. J., Arvanitis, M., Lohr, K. N., Middleton, J. C., & Jonas, D. E. (2014). Transitional care interventions to prevent readmissions for persons with heart failure. Annals of Internal Medicine, 160(11), 774–784.

Fixsen, D. L., Naoom, S. F., Blase, K. A., Friedman, R. M., & Wallace, F. (2005). Implementation research: A synthesis of the literature. University of South Florida, Louis de la Parte Florida Mental Health Institute.

Kane, J. M., Robinson, D. G., Schooler, N. R., Mueser, K. T., Penn, D. L., Rosenheck, R. A., Addington, J., Brunette, M. F., Correll, C. U., Estroff, S. E., Marcy, P., Robinson, J., Meyer-Kalos, P. S., Gottlieb, J. D., Glynn, S. M., Lynde, D. W., Pipes, R., Kurian, B. T., Miller, A. L., & Heinssen, R. K. (2016). Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. American Journal of Psychiatry, 173(4), 362–372.

Knudsen, E. I. (2004). Sensitive periods in the development of the brain and behavior. Journal of Cognitive Neuroscience, 16(8), 1412–1425.

Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., & Nathan, D. M. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393–403.

McGorry, P. D., Killackey, E., & Yung, A. (2008). Early intervention in psychosis: Concepts, evidence and future directions. World Psychiatry, 7(3), 148–156.

Shonkoff, J. P., Garner, A. S., Siegel, B. S., Dobbins, M. I., Earls, M. F., McGuinn, L., Pascoe, J., & Wood, D. L. (2012). The lifelong effects of early childhood adversity and toxic stress. Pediatrics, 129(1), e232–e246.

Stanton, M. P., & Dunkin, J. W. (2018). Community case management and care coordination outcomes. Professional Case Management, 23(4), 172–181.

Wang, P. S., Berglund, P., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005). Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 603–613.

Zwaigenbaum, L., Bauman, M. L., Stone, W. L., Yirmiya, N., Estes, A., Hansen, R. L., McPartland, J. C., Natowicz, M. R., Rozga, A., Sigman, M., Vismara, L., Warren, Z., Wetherby, A., Wiseman, F., & Wetherby, A. (2015). Early identification of autism spectrum disorder: Recommendations for practice and research. Pediatrics, 136(Suppl 1), S10–S40.

 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

How Nursing Professionals Can Lower the Global Chronic Disease Burden

Portrait of young nurse with badge crossing arms and smiling at camera

Written by Deboshree Bhattacharjee,

Health problems can be frustrating enough, but they somehow feel worse when we realize we could have prevented them. We could have taken steps to avoid falling prey to ailments that now require long-term management.

The world’s chronic disease burden can be distressing. The Peterson KFF tracker reports that chronic diseases are a leading cause of death. Whether it is hypertension, kidney disease, or chronic obstructive pulmonary disease (COPD), they continue to affect people despite advancements in medical treatment.

In the US, these conditions comprise 80% of the primary causes of death. While not all conditions are preventable, several connect directly to physical inactivity and substance abuse. 

Nursing professionals can play a significant role in transforming this state of affairs, provided they have a community and regulatory support system.

 

Recommending and Supporting Patients Through Preventive Steps

The most impactful intervention for avoiding chronic disease is to recognize the possibility of it developing from an early stage in a person’s life. Nurses, who may interact with patients across their lifespan, can deliver tailored recommendations that can improve health outcomes.

For example, a 2024 study in the European Respiratory Review explains that COPD does not always develop in adulthood due to smoking or pollution exposure. The scholars assert that this chronic disease is also connected to early respiratory infections and poor nutrition. 

“It has been proposed that COPD (and many other chronic diseases) results from different dynamic and cumulative gene–environment interactions occurring over the lifetime of the individual.” – Rosa Faner et al., Researcher, European Respiratory Review.

This makes it crucial to study early-life influences and take the necessary steps to reduce the risk of developing the illness. Even for conditions like cancer, timely interventions may lower an individual’s risk to some extent. This is especially true for obesity-related cancers. 

A British Journal of Cancer study notes that large-scale weight management may be able to prevent such cancers. GLP-1 agonists (glucagon-like-peptide) have been found to be a potent pharmacotherapy approach for managing obesity. Lifestyle-based interventions, such as dietary and exercise changes, can also be supporting agents.

Nurses can recommend data-backed preventive approaches for chronic illness and help patients follow through on them. This requires a deeper and more intimate relationship with a patient than a physician may be able to build or have the time for. A nurse’s focus on active listening and empathy is essential.

 

Steering Patient-Centric Research Based on Behavioral Cues

Another far-reaching way nursing practitioners can impact public health is through research that is genuinely patient-centered. In both inpatient and outpatient settings, nurses have the opportunity to observe patients closely. Behavioral cues can reveal a great deal about how a patient is coping with a condition and whether they are adhering to their medication.

Consistency and proactive caution are vital in preventing and managing chronic disease. In 2024, a research study in the International Journal of General Medicine found that narrative nursing decreased the negative emotions perceived by patients with digestive tract cancers. The core tenets of such nursing include understanding patients’ conditions and needs through their own narratives to deliver personalized care.

Working professionals who pursue a Doctor of Nursing Practice online can learn to apply scientific inquiry and technology to conduct further research in these areas. At the same time, they can continue to fulfill their current roles and remain connected to ground-level patient care.

According to Wilkes University, developing leadership skills to advance nursing practice is a strong step toward applying research to solve global health problems. This strategy equips you to shape the regulatory and policy framework while contributing insightfully with patient behavioral cues. 

 

Extending Patient Care Through Telehealth and Virtual Means

For nurses, maintaining continuity of care is paramount. It ensures that people with chronic illness or those at risk of developing it have support and guidance. Unfortunately, many people in remote and rural areas lack reliable access to healthcare. This increases their risk of developing chronic ailments.

Telehealth and digitally administered care can fill this gap. Regular sessions help nurses look for warning signs and recommend immediate action. 

For example, physically restricting conditions such as arthritis can often impact mental health. Individuals who feel disconnected from their peers and family members can experience isolation and loneliness. 

It does not bode well for those with a greater risk of developing depression, another chronic illness. A 2026 Gallup poll finds that more than 19% of US adults report having or receiving treatment for depression. This translates to roughly 51 million Americans. Nurses who track patients’ health over time can notice early signs of a depressive episode, such as tiredness and mood swings. 

It is heartening that alternative models of nursing care are becoming popular. It can bring substantial improvements in dealing with chronic illnesses among people who find in-person care difficult due to various reasons. Cost, travel, and social stigma are notable factors that virtual care can address.

 

FAQs

1. How can nurses help prevent chronic ailments?

Nurses can play a crucial role in preventing chronic disease by educating patients about healthy lifestyles and encouraging regular screenings. They can also monitor early warning signs and support long-term behavior changes. This personalized care and ongoing communication can help patients reduce risks associated with conditions such as diabetes, heart disease, and COPD.

2. Why is telehealth important in managing chronic diseases?

Telehealth can improve access to healthcare for patients in rural and remote communities. Through virtual consultations, nurses can monitor symptoms, provide follow-up care, and encourage adherence to medication. They can identify early signs of mental health concerns. Continuity of care enhances long-term health outcomes for people with chronic illnesses.

3. What role does patient-centered research play in limiting the chronic disease burden?

Patient-centered research allows healthcare professionals to understand how individuals experience chronic illnesses and respond to treatment plans. During patient interactions, nurses can observe behavioral patterns, emotional responses, and roadblocks to medication adherence. These insights can guide more personalized interventions and improve healthcare delivery. Over time, a research-focused approach can support policies for managing chronic diseases.

 

Nursing and the Global Chronic Disease Burden

Leading Causes of Death Chronic diseases account for 80% of the top causes of death in the U.S.
COPD Risk Factors Early respiratory infections and poor nutrition may contribute to the onset of COPD later in life.
Narrative Nursing Outcomes Narrative nursing interventions were found to reduce negative emotions among patients with digestive tract cancers.
Depression in the U.S. More than 19% of US adults report having or receiving treatment for depression, representing roughly 51 million people.
Role of Telehealth Virtual care models improve healthcare access for underserved and remote populations managing chronic illnesses.

 

Unburdening the World From Chronic Disease

The chronic disease burden remains a challenge for healthcare workers and policymakers all over the world. Evolving medical technologies have addressed some of the risk factors, making advanced treatment possible. However, nursing support is imperative for the smooth implementation of these changes in ways that benefit diverse patient communities.

Helping their patients through preventive steps to avoid chronic disease and actively participating in research initiatives can ease the burden. Nursing practitioners should also develop greater enthusiasm toward telehealth and digital care roles. These will be necessary to expand the ambit of care for underserved populations, who may also be more susceptible to chronic illness.

 

References:

Imani Telesford, Matthew McGough, Delaney Tevis, and Lynne Cotter   (2025). How has the burden of chronic diseases in the U.S. and peer nations changed over time? Retrieved from Peterson-KFF Health System Tracker

Rosa Faner, Michael H. Cho, and Gerard H. Koppelman (2024). Towards early detection and disease interception of COPD across the lifespan. Retrieved from European Respiratory Review

Harris, M., Brown, J. & Renehan, A.G. Preventing obesity-related cancer with the revolution in obesity management: the challenges of undertaking a clinical trial and potential solutions. British Journal of Cancer. Retrieved from BJC.

Zhng, Y. (2024). Effect of Narrative Nursing Intervention on Patients with Specific Digestive Tract Malignancies (Esophageal, Gastric, and Intestinal Cancers): A Retrospective Study. International Journal of General Medicine. Retrieved from Taylor and Francis.

Doctor of Nursing Practice (DNP) Program (2026). Wilkes University. Retrieved from the Wilkes University website.

Dan Witters (2026). U.S. Depression Rate Remains Elevated. Gallup. Retrieved from the Gallup website.

 

Author Bio:

Deboshree Bhattacharjee likes telling stories that delight and engage. Her focus areas include lifestyle, parenting, health & wellness, and technology. Besides writing, she also edits and strategizes content. Every morning, she wakes up with the northern lights in her eyes and chalks out travel plans.

 

 

 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification